Mice were injected three times at 2 week intervals with the adjuvant MPL+TDM or phosphate-buffered saline. Two weeks after the last injection, all mice were challenged subcutaneously with a tumorgenic dose of B16 tumor and observed for 40 days. The adjuvant hastened the time at which tumors appeared (P = 0.02).
|Number of pages||3|
|Journal||International Journal of Immunopharmacology|
|State||Published - 1 Jan 1996|